Protocol - Tobacco Brand and Variety - Cigarettes
Description
Four questions used to determine the type of cigarette brand that is most often used by the respondent.
Specific Instructions
Although the National Survey on Drug Use and Health (NSDUH) only asks about Marlboro in Q3, the PhenX Working Group (WG) feels other brands could be asked about as well. The CEP feels the question could be asked without brand.
While the source instrument was developed to be administered by computer, the WG acknowledges these questions can be administered in a noncomputerized format.
The Content Expert Panel suggests investigators consider nicotine as derived from any source, including both natural and synthetic, when administering this protocol.
The Content Expert Panel recommends investigators substitute people-first language (i.e. replace behavior-based labels such as “smoker” with “people who smoke”) as outlined in Hefler, M. et al 2023, which may differ from the original protocol text.
Availability
Protocol
1. What brand of cigarettes do you usually smoke?
- 1 [ ] 1839
2 [ ] 305’s
3 [ ] Alpine
4 [ ] American Spirit
5 [ ] Basic
6 [ ] Carlton
7 [ ] Camel
8 [ ] Capri
9 [ ] Carlton
10 [ ] Carnival
11 [ ] Cheyenne
12 [ ] Decade
13 [ ] Djarum
14 [ ] Doral
15 [ ] Dunhill
16 [ ] Eve
17 [ ] Exeter
18 [ ] Fortuna
19 [ ] GPC
20 [ ] Grand Prix
21 [ ] Kent
22 [ ] Kentucky’s Best
23 [ ] King Mountain
24 [ ] Kool
25 [ ] L&M
26 [ ] Liggett Select
27 [ ] Lucky Strike
28 [ ] Marlboro
29 [ ] Maverick
30 [ ] Merit
31 [ ] Misty
32 [ ] Monarch
33 [ ] Montclair
34 [ ] More
35 [ ] Mustang
36 [ ] Nat Sherman
37 [ ] Native
38 [ ] Newport
39 [ ] Old Gold
40 [ ] Palermo
41 [ ] Pall Mall
42 [ ] Parliament
43 [ ] Players
44 [ ] Pyramid
45 [ ] Salem
46 [ ] Saratoga
47 [ ] Seneca
48 [ ] Shield
49 [ ] Signal
50 [ ] Sonoma
51 [ ] Tahoe
52 [ ] Tareyton
53 [ ] Tourney
54 [ ] USA Gold
55 [ ] Virginia Slims
56 [ ] Wave
57 [ ] Wildhorse
58 [ ] Winston
59 [ ] Vuse
60 [ ] Remington
61 [ ] Smoker’s Choice
62 [ ] Some other brand
2. Were the cigarettes you smoked during the past 30 days menthol?
- 1 [ ] Yes
2 [ ] No
[ ] Don’t Know/Refused
3. IF (Q1=28] What length were the Marlboro cigarettes you smoked most often during the past 30 days? Were they shorts, regulars (also known as king-sized), or 100s?
- 1 [ ] Shorts
2 [ ] Regulars or king-sized
3 [ ] 100s
4. During the past 30 days, that is, since [DATEFILL], have you smoked part or all of a roll-your-own tobacco cigarette?
- 1 [ ] Yes
2 [ ] No
[ ] Don’t Know/Refused
Personnel and Training Required
None
Equipment Needs
None
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Child, Adolescent, Adult
Participants
Adolescents and adults (12+)
Selection Rationale
The protocol from the 2021 National Survey on Drug Use and Health (NSDUH) and PATH Study Wave 7 were selected because these surveys give a comprehensive assessment of tobacco use among the civilian, noninstitutionalized population of the United States. NSDUH was initiated in 1971, and it is currently conducted on an annual basis. NSDUH is a survey that includes substance use and is administered to individuals aged 12 and older.
The PATH Study is a nationally representative, in-person longitudinal cohort study of non-users and users of tobacco products and those at risk for tobacco use across the United States. Respondents 12 years old and up are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the U.S. Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.
Language
English, Other languages available at source
Standards
Standard | Name | ID | Source |
---|
Derived Variables
None
Process and Review
The Tobacco Regulatory Research (TRR) Content Expert Panel (CEP) reviewed the measures in the Tobacco Regulatory Research collection in February 2024.
Guidance from the TRR CEP includes:
• Updated protocol
Previous version in Toolkit archive (link)
Protocol Name from Source
National Survey on Drug Use and Health (NSDUH), 2021, Population Assessment of Tobacco and Health (PATH) Study Wave 7
Source
Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2020). 2021 National Survey on Drug Use and Health (NSDUH): Draft Web Specifications for Programming (English Version). Substance Abuse and Mental Health Services Administration, Rockville, MD. Questions CG11, CG11a, CG12, CGMENTH1, CGLNTH, CG14.
National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. [https://www.icpsr.umich.edu/files/NAHDAP/pathstudy/Final%20PATH%20Wave%207%20English%20Adult%20Questionnaire.pdf]
General References
Hefler, M., Durkin, S.J., Cohen, J.E., Henriksen, L., OConnor, R., Barnoya, J., Hill, S.E. and Malone, R.E., 2023. New policy of people-first language to replace ‘smoker’, ‘vaper’, ‘ tobacco user’ and other behaviour-based labels. Tobacco control, 32(2), pp.133-134.
Sharma, A., Fix, B. V., Delnevo, C., Cummings, K. M., & OConnor, R. J. (2016). Trends in market share of leading cigarette brands in the USA: national survey on drug use and health 2002–2013. BMJ open, 6(1).
Budenz A, Grana R. Cigarette Brand Use and Sexual Orientation: Intersections With Gender and Race or Ethnicity. (2021). Prev Chronic Dis, 18: E94. doi: 10.5888/pcd18.210160.
Protocol ID
730708
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Brand | ||||
PX730708010000 | What brand of cigarettes do you usually smoke? | N/A | ||
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Marlboro | ||||
PX730708030000 | What length were the Marlboro cigarettes you more | N/A | ||
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Menthol | ||||
PX730708020000 | Were the cigarettes you smoked during the more | N/A | ||
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Own_Rolled | ||||
PX730708040000 | During the past 30 days, that is, since more | N/A |
Measure Name
Tobacco Brand and Variety
Release Date
October 31, 2024
Definition
This measure consists of questions used to determine the tobacco product brand and type used by the respondent most often.
Purpose
This measure is used to assess the type and brand of tobacco product used by respondents.
Keywords
Tobacco Regulatory Research, TRR, cigar brand, cigar, cigar type, cigar variety, tobacco brand, tobacco variety, little cigars, cigarillos, TUS-CPS, agent, brand, tobacco type, tobacco product, Cigarette smoking, menthol, cigarettes, regulars, smokeless tobacco, snus, moist snuff, dip tobacco, split tobacco, Chewing Tobacco, flavors, Population Assessment of Tobacco and Health, PATH, smokeless, dip, Snuff, spit
Measure Protocols
Protocol ID | Protocol Name |
---|---|
730704 | Tobacco Brand and Variety - Smokeless Tobacco |
730707 | Tobacco Brand and Variety - Cigars |
730708 | Tobacco Brand and Variety - Cigarettes |
Publications
There are no publications listed for this protocol.